NIH-funded research NIH-funded research

Developing new contraceptive methods for men and women

Official title: BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES

Funded at Sri International · NIH-11177532 · Data updated 2026-11-12

This study is working on developing new, safe, and effective birth control options that help prevent pregnancy by affecting ovulation and sperm function, so people can have more affordable and accessible choices for contraception.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSri International
NIH-funded
Lab location1 site (Menlo Park, United States)
Project startMay 31, 2024
Project endMay 29, 2026
Funding year2024
Award (this year)$1,479,511
NIH project number75N94020D00003-0-759402400001-1
Project IDNIH-11177532 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options, particularly those interested in innovative methods.

Less likely to help

Patients who are not seeking contraceptive solutions or those who have contraindications to hormonal contraceptives may not benefit from this research.

What this research studies

This research focuses on creating safe and effective contraceptives by disrupting normal ovulation and sperm function. The Biological Testing Facility plays a key role in evaluating new drug formulations and delivery systems through various preclinical activities, including laboratory assays and animal studies. By managing the development process, the facility aims to produce contraceptive compounds that meet regulatory standards for clinical trials. Patients may benefit from innovative contraceptive options that are affordable and accessible.

Why it matters

Potential benefit: If successful, this research could lead to the development of new contraceptive methods that are safer and more effective for patients.

How similar studies have gone: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new methods.

Where this research is happening

  • Sri International
    Menlo Park, United States
    Active

Researchers

  • Principal investigator: Bunin, Deborah — Sri International
  • Study coordinator: Bunin, Deborah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.